Tag Archive for: generic drugs

Despite a patent extension, Merck’s muscle relaxant reversal injection is now facing potential generic competition from Hikma Pharmaceuticals, which is seeking the FDA’s approval for a copycat version.

The Chicago-based drugmaker has been counting on revenues from its newer immunology medicines to help make up for declining sales of its blockbuster arthritis drug Humira.

Despite strong sales of its blockbuster drug Dupixent, Sanofi reported that its fourth-quarter 2023 operating income dropped 5% due to a weaker U.S. dollar, high expenses and generic competition.

The world’s largest generic drugs maker announced on Wednesday that it will divest its active pharmaceutical ingredient (API) unit to focus on its core business.

For Sandoz, Monday’s deal with Coherus represents its first major contract since spinning out of Novartis in October 2023.

Sun Pharma first moved to acquire Taro in May 2007, at the time offering $454 million or $7.75 per share.

The European Commission upheld exclusive marketing protection in Europe for Biogen’s multiple sclerosis therapy Tecfidera until February 3, 2025, staving off generic competition.

While the patent for Biogen’s drug has expired in the United States, it had scored a win in Europe in March.

It is the biggest change to existing medical laws in two decades, aiming to ensure all Europeans have access to innovative treatments and drugs.

An interview with Dinakaran Balasubramanian, head commercial strategy & insights, biologics, Dr. Reddy’s Laboratories.